Log In
Print
BCIQ
Print
Print this Print this
 

Heplisav (V270)

Also known as: HBV vaccine (HBV-ISS vaccine)

  Manage Alerts
Collapse Summary General Information
Company Dynavax Technologies Corp.
DescriptionHepatitis B surface antigen (HBsAg) given with immunostimulatory DNA sequences that target toll-like receptor 9 (TLR9)
Molecular Target Toll-like receptor 9 (TLR9)
Mechanism of ActionVaccine
Latest Stage of DevelopmentRegistration
IndicationHepatitis B virus (HBV)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today